Literature DB >> 22460606

Prioritization of SNPs for genome-wide association studies using an interaction model of genetic variation, gene expression, and trait variation.

Hyojung Paik1, Junho Kim, Sunjae Lee, Hyoung-Sam Heo, Cheol-Goo Hur, Doheon Lee.   

Abstract

The identification of true causal loci to unravel the statistical evidence of genotype-phenotype correlations and the biological relevance of selected single-nucleotide polymorphisms (SNPs) is a challenging issue in genome-wide association studies (GWAS). Here, we introduced a novel method for the prioritization of SNPs based on p-values from GWAS. The method uses functional evidence from populations, including phenotype-associated gene expressions. Based on the concept of genetic interactions, such as perturbation of gene expression by genetic variation, phenotype and gene expression related SNPs were prioritized by adjusting the p-values of SNPs. We applied our method to GWAS data related to drug-induced cytotoxicity. Then, we prioritized loci that potentially play a role in druginduced cytotoxicity. By generating an interaction model, our approach allowed us not only to identify causal loci, but also to find intermediate nodes that regulate the flow of information among causal loci, perturbed gene expression, and resulting phenotypic variation.

Entities:  

Mesh:

Year:  2012        PMID: 22460606      PMCID: PMC3887803          DOI: 10.1007/s10059-012-2264-7

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  42 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  PharmGKB: the Pharmacogenetics Knowledge Base.

Authors:  Micheal Hewett; Diane E Oliver; Daniel L Rubin; Katrina L Easton; Joshua M Stuart; Russ B Altman; Teri E Klein
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

Review 3.  Polymorphisms in the ABC drug transporter gene MDR1.

Authors:  U Brinkmann; M Eichelbaum
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

Review 4.  DNA-based drug interactions of cisplatin.

Authors:  M Crul; R C A M van Waardenburg; J H Beijnen; J H M Schellens
Journal:  Cancer Treat Rev       Date:  2002-12       Impact factor: 12.111

5.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

6.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

7.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 8.  The human hepatic cytochromes P450 involved in drug metabolism.

Authors:  S A Wrighton; J C Stevens
Journal:  Crit Rev Toxicol       Date:  1992       Impact factor: 5.635

9.  Prediction of cancer prognosis with the genetic basis of transcriptional variations.

Authors:  Hyojung Paik; Eunjung Lee; Inho Park; Junho Kim; Doheon Lee
Journal:  Genomics       Date:  2011-03-16       Impact factor: 5.736

10.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

View more
  1 in total

Review 1.  Genomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancers.

Authors:  R Pranavchand; B M Reddy
Journal:  J Postgrad Med       Date:  2016 Jul-Sep       Impact factor: 1.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.